Illumina's Inclusion in China's Unreliable Entity List: Patent Wars, Geopolitical Risks, and Compliance Strategies

By Jianwei (Jerry) Fang and Xiaoyu (Arthur) Jin and Haoyi Sun

Jianwei (Jerry) Fang, Xiaoyu (Arthur) Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications... Read More

Regulatory Developments in the China Pharmaceutical and Medtech Sector in 2024, and the Outlook for 2025

Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences... Read More

In the News: China Restricts Outbound Investments; Shenzhen Foreign Hospitals; and US Companies Survey

By Krista Lee

China to block Chinese firms from investing in the U.S. amid tariff war; Shenzhen launches incentives for foreign-owned... Read More

Law Digest: State Council, Provisions for Implementation of the Anti-Foreign Sanctions Law

国务院实施«中华人民共和国反外国制裁法»的规定

By Susan Mok

China specifies penalties for a failure to implement sanction countering measures Read More

Law Digest: State Council, Provisions for Handling Foreign-Related Intellectual Property Disputes

国务院关于涉外知识产权纠纷处理的规定

By Susan Mok

State Council restricts provision of evidence outside of mainland China for IP cases Read More

Banking and Finance

Law Digest: National Financial Regulatory Administration, Circular on Matters Relevant to the Acquisition by Hong Kong and Macao Financial Institutions of Equity Stakes in Insurance Companies

国家金融监督管理总局关于香港、澳门金融机构入股保险公司有关事项的通知

By Susan Mok

Total asset requirement is relaxed for Hong Kong and Macao insurance company investments Read More